390 results on '"Copland, M."'
Search Results
2. Mtss1 is a critical epigenetically regulated tumor suppressor in CML
3. P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE
4. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
5. The Life Cycle
6. Parasites and Predators
7. A ‘telomere-associated secretory phenotype’ cooperates with BCR-ABL to drive malignant proliferation of leukemic cells
8. In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors
9. EZH2 in normal and malignant hematopoiesis
10. The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials
11. T cell subsets do not alter on decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: Data from the DESTINY trial: 290
12. Uncovering the BCR-ABL1 tyrosine kinase independent signature in chronic myeloid leukaemia stem cells: 291
13. De-escalation of tyrosine kinase inhibitor treatment in chronic myeloid leukaemia patients with excellent molecular responses: Initial safety results from the DESTINY trial: 13
14. SPIRIT 2: an NCRI randomised study comparing dasatinib with imatinib in patients with newly diagnosed chronic myeloid leukaemia - 2 year follow up: 27
15. The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells
16. SPIRIT 2: an NCRI randomised study comparing dasatinib with imatinib in patients with newly diagnosed CML: 1
17. THE USE OF AUTOLOGOUS SERUM EYEDROPS IN SEVERE OCULAR GRAFT VERSUS HOST DISEASE: PH-P394
18. Entomopathogenic nematodes (Nematoda: Steinernematidae, heterorhabditidae) as control agents forParahypopta caestrum, a pest in the culture ofAsparagus officinalis
19. Aspects of prey relations in the coccidophagous ladybird Chilocorus nigritus relevant to its use as a biological control agent of scale insects in temperate glasshouses
20. Le spliceosome : un autre mécanisme de régulation des gènes impliqués dans l’hétérogénéité intra-clonale de la Leucémie Myéloïde Chronique ?
21. The Spliceosome: An Another Regulating System of Gene Expression Deregulated in CP-CML CD34+CD15- Cells
22. BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry
23. Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia
24. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients
25. Identification of novel therapeutic targets to eliminate chronic myeloid leukaemia stem cells: 4
26. The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34 + CML stem/progenitor cells
27. A proactive approach to plerixafor use and subsequent apheresis can reduce failed autologous PBSC mobilization rates to virtually zero after two mobilization attempts: a single-centre series of 40 consecutive PBSC mobilization episodes using plerixafor: P1080
28. Rationalising strategies to prevent cytomegalovirus disease in recipients of T cell depleted allogeneic haemopoietic stem cell transplants (HSCT): identification of a subset of patients who reactivate but can be safely monitored: 37
29. A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease
30. The impact of second generation tyrosine kinase inhibitors on the outcome of allogeneic stem cell transplantation for chronic myeloid leukaemia: 48
31. Studies on the female reproductive system in the Chalcidoidea
32. The farnesyl transferase inhibitor BMS-214662 selectively targets primary CML stem cells trough activation of caspases: 322
33. BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients
34. Effect of temperature on the egg viability and duration of egg development ofParahypopta caestrum
35. Larval morphology and development of the parasitoidDacnusa sibirica [Hym.: Braconidae] in the leafminer hostChromatomyia syngenesiae
36. Honeydew: A food resource or arrestant for the mealybug predatorCryptolaemus montrouzieri?
37. The novel, dual Src/Bcr-Abl kinase inhibitor, BMS-354825, does not overcome the intrinsic insensitivity of quiescent chronic myeloid leukaemia stem cells to imatinib: 245
38. Host finding byCryptolaemus montrouzieri (Col., Coccinellidae) a predator of mealybusgs (Hom., Pseudococcidae)
39. The use of a risk group stratification in the management of invasive fungal infection: a prospective validation
40. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections
41. Real time PCR is superior to ELISA for the early detection of invasive fungal infection in haematology patients
42. Real-time PCR is superior to galactomannan and mannan ELISA for the early detection of invasive fungal infection in hematology patients
43. Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)
44. Effects of various aphid foods on Cycloneda sanguinea
45. Food consumption and utilisation by larvae of two coccinellid predators, Scymnus levaillanti and Cycloneda sanguinea, on cotton aphid, Aphis gossypii
46. Maximum feeding potential of larvae and adults of the scale insect predator, Chilocorus nigritus with a new method of estimating food intake
47. A RETROSPECTIVE FOLLOW-UP STUDY OF ORAL ANTICOAGULANT CONTROL AND HAEMORRHAGIC COMPLICATIONS IN AN ELDERLY POPULATION WITH ATRIAL FIBRILLATION
48. Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
49. S124 IDENTIFICATION OF THE DOPAMINE AND SEROTONIN TRANSPORTERS SLC6A3 AND SLC6A4 AS NOVEL SURVIVAL FACTORS IN LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKAEMIA
50. S126 COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.